标题
Mechanisms of docetaxel resistance in prostate cancer: The key role played by miRNAs
作者
关键词
miRNAs, Docetaxel resistance, Prostate cancer, Drug resistance, Taxane
出版物
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
Volume 1875, Issue 1, Pages 188481
出版商
Elsevier BV
发表日期
2020-11-17
DOI
10.1016/j.bbcan.2020.188481
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Circulating miR-141 and miR-375 are associated with treatment outcome in metastatic castration resistant prostate cancer
- (2020) A. H. Zedan et al. Scientific Reports
- NPRL2 promotes docetaxel chemoresistance in castration resistant prostate cancer cells by regulating autophagy through the mTOR pathway
- (2020) Shengjun Luo et al. EXPERIMENTAL CELL RESEARCH
- Inhibition of the Lysophosphatidylinositol Transporter ABCC1 Reduces Prostate Cancer Cell Growth and Sensitizes to Chemotherapy
- (2020) Aikaterini Emmanouilidi et al. Cancers
- STAT3 inhibition with galiellalactone effectively targets the prostate cancer stem-like cell population
- (2020) Giacomo Canesin et al. Scientific Reports
- Targeting Ezh2 could overcome docetaxel resistance in prostate cancer cells
- (2019) Xiaofu Qiu et al. BMC CANCER
- EMT Markers in Locally-Advanced Prostate Cancer: Predicting Recurrence?
- (2019) Katia A. Cheaito et al. Frontiers in Oncology
- MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancer
- (2019) Nicholas G. Nickols et al. PROSTATE CANCER AND PROSTATIC DISEASES
- miR-205 enhances radiation sensitivity of prostate cancer cells by impairing DNA damage repair through PKCε and ZEB1 inhibition
- (2019) Rihan El Bezawy et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Inhibition of enhancer of zeste homolog 2 (EZH2) overcomes enzalutamide-resistance in castration-resistance prostate cancer
- (2019) Yunfeng Bai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CD44 Promotes Migration and Invasion of Docetaxel-Resistant Prostate Cancer Cells Likely via Induction of Hippo-Yap Signaling
- (2019) Chih-Jen Lai et al. Cells
- Emerging therapeutic targets for patients with advanced prostate cancer
- (2019) Fred Saad et al. CANCER TREATMENT REVIEWS
- Long noncoding RNA DANCR contributes to docetaxel resistance in prostate cancer through targeting the miR-34a-5p/JAG1 pathway
- (2019) Yongliang Ma et al. OncoTargets and Therapy
- Docetaxel Combined with Thymoquinone Induces Apoptosis in Prostate Cancer Cells via Inhibition of the PI3K/AKT Signaling Pathway
- (2019) Santosh Kumar Singh et al. Cancers
- Nanoscale delivery systems for microRNAs in cancer therapy
- (2019) Sanda Boca et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Androgen receptor‐related micro RNAs in prostate cancer and their role in antiandrogen drug resistance
- (2019) Samaneh Rezaei et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Role of hypoxia in cancer therapy by regulating the tumor microenvironment
- (2019) Xinming Jing et al. Molecular Cancer
- FOXM1 contributes to docetaxel resistance in castration-resistant prostate cancer by inducing AMPK/mTOR-mediated autophagy
- (2019) Jian-zhong Lin et al. CANCER LETTERS
- LncRNA NEAT1 promotes docetaxel resistance in prostate cancer by regulating ACSL4 via sponging miR-34a-5p and miR-204-5p
- (2019) Xingkang Jiang et al. CELLULAR SIGNALLING
- MiR‐129‐5p promotes docetaxel resistance in prostate cancer by down‐regulating CAMK2N1 expression
- (2019) Cheng Wu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- The stem cell inhibitor salinomycin decreases colony formation potential and tumor‐initiating population in docetaxel‐sensitive and docetaxel‐resistant prostate cancer cells
- (2019) Martina Gruber et al. PROSTATE
- MDA-9/Syntenin (SDCBP) Is a Critical Regulator of Chemoresistance, Survival and Stemness in Prostate Cancer Stem Cells
- (2019) Sarmistha Talukdar et al. Cancers
- Long non-coding RNA CASC2 regulates Sprouty2 via functioning as a competing endogenous RNA for miR-183 to modulate the sensitivity of prostate cancer cells to docetaxel
- (2018) Weiyin Gao et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Role of chemotherapy in prostate cancer
- (2018) JeannyB Aragon-Ching et al. ASIAN JOURNAL OF ANDROLOGY
- MicroRNA-195 regulates docetaxel resistance by targeting clusterin in prostate cancer
- (2018) Xiaokun Ma et al. BIOMEDICINE & PHARMACOTHERAPY
- microRNA-323 upregulation promotes prostate cancer growth and docetaxel resistance by repressing p73
- (2018) Qiruo Gao et al. BIOMEDICINE & PHARMACOTHERAPY
- mi R -27b and mi R -34a enhance docetaxel sensitivity of prostate cancer cells through inhibiting epithelial-to-mesenchymal transition by targeting ZEB1
- (2018) Guangwei Zhang et al. BIOMEDICINE & PHARMACOTHERAPY
- Docetaxel-mediated autophagy promotes chemoresistance in castration-resistant prostate cancer cells by inhibiting STAT3
- (2018) Fei Hu et al. CANCER LETTERS
- Role of MicroRNAs in Treatment Response in Prostate Cancer
- (2018) Anshuli Razdan et al. CURRENT CANCER DRUG TARGETS
- Posttranscriptional Regulation of Human Antigen R by miR-133b Enhances Docetaxel Cytotoxicity Through the Inhibition of ATP-Binding Cassette Subfamily G Member 2 in Prostate Cancer Cells
- (2018) Hui Liu et al. DNA AND CELL BIOLOGY
- MicroRNA-223-3p regulates cell chemo-sensitivity by targeting FOXO3 in prostatic cancer
- (2018) Qiang Feng et al. GENE
- Inhibiting autophagy overcomes docetaxel resistance in castration-resistant prostate cancer cells
- (2018) Quan Wang et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Long noncoding RNA MALAT1 enhances the docetaxel resistance of prostate cancer cells via miR-145-5p-mediated regulation of AKAP12
- (2018) Dong Xue et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Treating cancer with microRNA replacement therapy: A literature review
- (2018) Nayer Hosseinahli et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Epithelial–mesenchymal-transition-inducing transcription factors: new targets for tackling chemoresistance in cancer?
- (2018) Jente van Staalduinen et al. ONCOGENE
- EMT: Mechanisms and therapeutic implications
- (2018) Mohini Singh et al. PHARMACOLOGY & THERAPEUTICS
- Hypoxia and Noncoding RNAs in Taxane Resistance
- (2018) Perla Pucci et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- MicroRNAs as potential therapeutics to enhance chemosensitivity in advanced prostate cancer
- (2018) Hui-Ming Lin et al. Scientific Reports
- PrLZ increases prostate cancer docetaxel resistance by inhibiting LKB1/AMPK-mediated autophagy
- (2018) Jin Zeng et al. Theranostics
- Acetyl-11-keto-β-boswellic acid suppresses docetaxel-resistant prostate cancer cells in vitro and in vivo by blocking Akt and Stat3 signaling, thus suppressing chemoresistant stem cell-like properties
- (2018) Yong-qing Liu et al. ACTA PHARMACOLOGICA SINICA
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- KLF4, a miR-32-5p targeted gene, promotes cisplatin-induced apoptosis by upregulating BIK expression in prostate cancer
- (2018) Lu Zhang et al. Cell Communication and Signaling
- Genetics and biology of prostate cancer
- (2018) Guocan Wang et al. GENES & DEVELOPMENT
- miR-17-3p Downregulates Mitochondrial Antioxidant Enzymes and Enhances the Radiosensitivity of Prostate Cancer Cells
- (2018) Zhi Xu et al. Molecular Therapy-Nucleic Acids
- miRNA-205 Nanoformulation Sensitizes Prostate Cancer Cells to Chemotherapy
- (2018) Prashanth Nagesh et al. Cancers
- Molecular Basis of Drug Resistance and Insights for New Treatment Approaches in mCRPC
- (2018) SILVANA GIACINTI et al. ANTICANCER RESEARCH
- Long non-coding RNA Linc00518 promotes paclitaxel resistance of the human prostate cancer by sequestering miR-216b-5p
- (2018) Junhui He et al. BIOLOGY OF THE CELL
- The RNA Binding Protein HuR: a Promising Drug Target for Anticancer Therapy
- (2018) Mingxia Wu et al. CURRENT CANCER DRUG TARGETS
- microRNA‐16‐5p enhances radiosensitivity through modulating Cyclin D1/E1–pRb–E2F1 pathway in prostate cancer cells
- (2018) Fang Wang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Dual responsive micelles capable of modulating miRNA-34a to combat taxane resistance in prostate cancer
- (2018) Feng Lin et al. BIOMATERIALS
- Addressing taxane resistance in metastatic castration-resistant prostate cancer: a focus on chaperone proteins
- (2017) Sebastien J Hotte Future Oncology
- Clinical significance of epithelial-mesenchymal transition markers in prostate cancer
- (2017) Sandy Figiel et al. HUMAN PATHOLOGY
- The Prostate Cancer Cells Resistant to Docetaxel as in vitro Model for Discovering MicroRNAs Predictive of the Onset of Docetaxel Resistance
- (2017) Lorenzo Bascetta et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Drug Resistance Driven by Cancer Stem Cells and Their Niche
- (2017) Marta Prieto-Vila et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Silencing of miR-193a-5p increases the chemosensitivity of prostate cancer cells to docetaxel
- (2017) Zhan Yang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Custirsen (OGX-011) combined with cabazitaxel and prednisone versus cabazitaxel and prednisone alone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (AFFINITY): a randomised, open-label, international, phase 3 trial
- (2017) Tomasz M Beer et al. LANCET ONCOLOGY
- The role of epithelial-mesenchymal transition drivers ZEB1 and ZEB2 in mediating docetaxel-resistant prostate cancer
- (2017) Karen Hanrahan et al. Molecular Oncology
- Cancer stem cells revisited
- (2017) Eduard Batlle et al. NATURE MEDICINE
- EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
- (2017) Tsukasa Shibue et al. Nature Reviews Clinical Oncology
- MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
- (2017) Rajesha Rupaimoole et al. NATURE REVIEWS DRUG DISCOVERY
- MicroRNA-181a promotes docetaxel resistance in prostate cancer cells
- (2017) Cameron M. Armstrong et al. PROSTATE
- Paclitaxel resistance development is associated with biphasic changes in reactive oxygen species, mitochondrial membrane potential and autophagy with elevated energy production capacity in lung cancer cells: A chronological study
- (2017) Satabdi Datta et al. TUMOR BIOLOGY
- Molecular complexity of taxane-induced cytotoxicity in prostate cancer cells
- (2017) Josef Mang et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Regulation of Docetaxel Sensitivity in Prostate Cancer Cells by hsa-miR-125a-3p via Modulation of Metastasis-Associated Protein 1 Signaling
- (2017) Jian-zhou Liu et al. UROLOGY
- Insulin-like growth factor-I induces chemoresistence to docetaxel by inhibiting miR-143 in human prostate cancer
- (2017) Xiao-Bing Niu et al. Oncotarget
- The UCA1/miR-204/Sirt1 axis modulates docetaxel sensitivity of prostate cancer cells
- (2016) Xu Wang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Hypoxia: A Double-Edged Sword in Cancer Therapy
- (2016) Hamed Manoochehri Khoshinani et al. CANCER INVESTIGATION
- miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1
- (2016) Yuan Wang et al. Molecular Cancer
- Diagnostic, prognostic and predictive value of cell-free miRNAs in prostate cancer: a systematic review
- (2016) Edgars Endzeliņš et al. Molecular Cancer
- The ERK–ZEB1 pathway mediates epithelial–mesenchymal transition in pemetrexed resistant lung cancer cells with suppression by vinca alkaloids
- (2016) L-Y Chiu et al. ONCOGENE
- Hypoxia-responsive miR-124 and miR-144 reduce hypoxia-induced autophagy and enhance radiosensitivity of prostate cancer cells via suppressing PIM1
- (2016) Hao Gu et al. Cancer Medicine
- A Targetable GATA2-IGF2 Axis Confers Aggressiveness in Lethal Prostate Cancer
- (2015) Samuel J. Vidal et al. CANCER CELL
- Taxane Resistance in Prostate Cancer Mediated by AR-Independent GATA2 Regulation of IGF2
- (2015) Stephen R. Plymate et al. CANCER CELL
- ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat
- (2015) S. Meidhof et al. EMBO Molecular Medicine
- The role of clusterin in prostate cancer: treatment resistance and potential as a therapeutic target
- (2015) Lateef A Muhammad et al. Expert Review of Anticancer Therapy
- The Upregulation of PI3K/Akt and MAP Kinase Pathways is Associated with Resistance of Microtubule-Targeting Drugs in Prostate Cancer
- (2015) Zhi Liu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- miR-138-Mediated Regulation of KINDLIN-2 Expression Modulates Sensitivity to Chemotherapeutics
- (2015) K. Sossey-Alaoui et al. MOLECULAR CANCER RESEARCH
- MicroRNA-328 directly targets p21-activated protein kinase 6 inhibiting prostate cancer proliferation and enhancing docetaxel sensitivity
- (2015) CHUNHUI LIU et al. Molecular Medicine Reports
- MicroRNA-145 Modulates Tumor Sensitivity to Radiation in Prostate Cancer
- (2015) Pijun Gong et al. RADIATION RESEARCH
- Androgen receptor splice variants circumvent AR blockade by microtubule-targeting agents
- (2015) Guanyi Zhang et al. Oncotarget
- Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer
- (2015) Emmanuel S. Antonarakis et al. JAMA Oncology
- IL-6 Inhibits the Targeted Modulation of PDCD4 by miR-21 in Prostate Cancer
- (2015) Biao Dong et al. PLoS One
- Bcl-2 family inhibition sensitizes human prostate cancer cells to docetaxel and promotes unexpected apoptosis under caspase-9 inhibition
- (2015) Hiroki Tamaki et al. Oncotarget
- Lycopene Enhances Docetaxel's Effect in Castration-Resistant Prostate Cancer Associated with Insulin-like Growth Factor I Receptor Levels
- (2015) Yaxiong Tang et al. NEOPLASIA
- Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer
- (2014) H-M Lin et al. BRITISH JOURNAL OF CANCER
- Androgen Receptor Splice Variants Determine Taxane Sensitivity in Prostate Cancer
- (2014) Maria Thadani-Mulero et al. CANCER RESEARCH
- Regulation of SOD2 and β-arrestin1 by interleukin-6 contributes to the increase of IGF-1R expression in docetaxel resistant prostate cancer cells
- (2014) Denglu Zhang et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Targeting the PI3K/Akt pathway in prostate cancer: Challenges and opportunities (Review)
- (2014) PAUL TOREN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Emerging targets to monitor and overcome docetaxel resistance in castration resistant prostate cancer (Review)
- (2014) L. MAGADOUX et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- NOTCH1 signaling promotes chemoresistance via regulating ABCC1 expression in prostate cancer stem cells
- (2014) Cheng Liu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Epithelial-to-Mesenchymal Transition Mediates Docetaxel Resistance and High Risk of Relapse in Prostate Cancer
- (2014) M. Marin-Aguilera et al. MOLECULAR CANCER THERAPEUTICS
- MicroRNAs and Drug Resistance in Prostate Cancers
- (2014) Feng Li et al. MOLECULAR PHARMACEUTICS
- Autophagy as a modulator and target in prostate cancer
- (2014) Jason M. Farrow et al. Nature Reviews Urology
- Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Polycomb protein EZH2 suppresses apoptosis by silencing the proapoptotic miR-31
- (2014) Q Zhang et al. Cell Death & Disease
- miR-205 impairs the autophagic flux and enhances cisplatin cytotoxicity in castration-resistant prostate cancer cells
- (2013) Marzia Pennati et al. BIOCHEMICAL PHARMACOLOGY
- Inhibition of ABCB1 Expression Overcomes Acquired Docetaxel Resistance in Prostate Cancer
- (2013) Y. Zhu et al. MOLECULAR CANCER THERAPEUTICS
- miR-200b suppresses cell proliferation, migration and enhances chemosensitivity in prostate cancer by regulating Bmi-1
- (2013) JUNJIE YU et al. ONCOLOGY REPORTS
- Circulating microRNA Profiling Identifies a Subset of Metastatic Prostate Cancer Patients with Evidence of Cancer-Associated Hypoxia
- (2013) Heather H. Cheng et al. PLoS One
- ABT-737, a small molecule Bcl-2/Bcl-xL antagonist, increases antimitotic-mediated apoptosis in human prostate cancer cells
- (2013) Ricardo Parrondo et al. PeerJ
- Epithelial-to-Mesenchymal Transition Leads to Docetaxel Resistance in Prostate Cancer and Is Mediated by Reduced Expression of miR-200c and miR-205
- (2012) Martin Puhr et al. AMERICAN JOURNAL OF PATHOLOGY
- Androgen Receptor on the Move: Boarding the Microtubule Expressway to the Nucleus
- (2012) M. Thadani-Mulero et al. CANCER RESEARCH
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Taxane-Induced Blockade to Nuclear Accumulation of the Androgen Receptor Predicts Clinical Responses in Metastatic Prostate Cancer
- (2011) M. S. Darshan et al. CANCER RESEARCH
- miR-143 decreases prostate cancer cells proliferation and migration and enhances their sensitivity to docetaxel through suppression of KRAS
- (2011) Bin Xu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Abiraterone and Increased Survival in Metastatic Prostate Cancer
- (2011) Johann S. de Bono et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evolving standards in the treatment of docetaxel-refractory castration-resistant prostate cancer
- (2011) E S Antonarakis et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Involvement of microRNA-21 in mediating chemo-resistance to docetaxel in androgen-independent prostate cancer PC3 cells
- (2010) Guo-hai Shi et al. ACTA PHARMACOLOGICA SINICA
- Class III -Tubulin Expression Predicts Prostate Tumor Aggressiveness and Patient Response to Docetaxel-Based Chemotherapy
- (2010) G. Ploussard et al. CANCER RESEARCH
- Kallikrein-Related Peptidase 7 Promotes Multicellular Aggregation via the α5β1Integrin Pathway and Paclitaxel Chemoresistance in Serous Epithelial Ovarian Carcinoma
- (2010) Ying Dong et al. CANCER RESEARCH
- Gamma-tocotrienol as an effective agent in targeting prostate cancer stem cell-like population
- (2010) Sze Ue Luk et al. INTERNATIONAL JOURNAL OF CANCER
- BMI1 silencing enhances docetaxel activity and impairs antioxidant response in prostate cancer
- (2010) Francesco Crea et al. INTERNATIONAL JOURNAL OF CANCER
- MiR-148a Attenuates Paclitaxel Resistance of Hormone-refractory, Drug-resistant Prostate Cancer PC3 Cells by Regulating MSK1 Expression
- (2010) Yasunori Fujita et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Induction of Clusterin by AKT--Role in Cytoprotection against Docetaxel in Prostate Tumor Cells
- (2010) B. Zhong et al. MOLECULAR CANCER THERAPEUTICS
- Drug resistance in metastatic castration-resistant prostate cancer
- (2010) Bostjan Seruga et al. Nature Reviews Clinical Oncology
- Serum miRNA-21: Elevated levels in patients with metastatic hormone-refractory prostate cancer and potential predictive factor for the efficacy of docetaxel-based chemotherapy
- (2010) Hai-Liang Zhang et al. PROSTATE
- MiR-34a attenuates paclitaxel-resistance of hormone-refractory prostate cancer PC3 cells through direct and indirect mechanisms
- (2010) Keitaro Kojima et al. PROSTATE
- Downregulation of miR-205 and miR-31 confers resistance to chemotherapy-induced apoptosis in prostate cancer cells
- (2010) N Bhatnagar et al. Cell Death & Disease
- Increased expression of class III β-tubulin in castration-resistant human prostate cancer
- (2009) S Terry et al. BRITISH JOURNAL OF CANCER
- Pak protein kinases and their role in cancer
- (2009) Bettina Dummler et al. CANCER AND METASTASIS REVIEWS
- A mutation in β-tubulin and a sustained dependence on androgen receptor signalling in a newly established docetaxel-resistant prostate cancer cell line
- (2009) Takahito Hara et al. CELL BIOLOGY INTERNATIONAL
- Dexamethasone enhances cell resistance to chemotherapy by increasing adhesion to extracellular matrix in human ovarian cancer cells
- (2009) Yu-Xia Chen et al. ENDOCRINE-RELATED CANCER
- Knockdown of p21-activated Kinase 6 Inhibits Prostate Cancer Growth and Enhances Chemosensitivity to Docetaxel
- (2009) Xingqiao Wen et al. UROLOGY
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
- Role of Sirtuin Histone Deacetylase SIRT1 in Prostate Cancer
- (2008) Brittney Jung-Hynes et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mitotic catastrophe and apoptosis induced by docetaxel in hormone-refractory prostate cancer cells
- (2008) Francesco Fabbri et al. JOURNAL OF CELLULAR PHYSIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now